MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK)
Market: HKEX |
Currency: HKD
Address: No. 108 Liuze Street
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and sale of medical devices for diabetes monitoring, treatment, and management in the People's Republic of China and internationally. The company offers Equil patch insulin pump systems; AiDEX and LinX continuous glucose monitoring systems; POCT analyzer systems; closed-loop artificial pancreas systems; blood glucose monitoring systems; Exactive Pro blood glucose, blood ketone, and uric acid monitoring system; and diabetes digital management software. It is also involved in scientific research and technical services; business services; wholesale and retail; manufacturing; and commercials. MicroTech Medical (Hangzhou) Co., Ltd. was incorporated in 2011 and is headquartered in Hangzhou, the People's Republic of China.
Show more
📈 MicroTech Medical (Hangzhou) Co., Ltd. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$6.62
-
Upside/Downside from Analyst Target:
11.89%
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
25-50%
-
Revenue Growth Range (1Y):
25-50%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for MicroTech Medical (Hangzhou) Co., Ltd.
| Date | Reported EPS |
|---|
| 2025-08-26 (estimated upcoming) | - |
| 2024-08-29 | - |
| 2024-03-26 | - |
| 2023-08-28 | - |
| 2023-03-26 | - |
| 2022-08-28 | - |
| 2022-03-24 | - |
| 2022-02-07 | - |
| 2021-12-25 | - |
| 2021-11-10 | - |
| 2021-10-04 | - |
📰 Related News & Research
No related articles found for "microtech medical".
